Volume : 09, Issue : 06, June – 2022



Authors :

Umesh Kumar*, Mr. Amit Dubey, Monika Parmar, Kalpana Prajapati,
Dr. Sailesh Kumar Ghatuary

Abstract :

Ophthalmic in situ gelling system of Suprofen was successfully formulated using polymeric combination of gelling agents Sodium Alginate, HPMC E 50 LV, HPMC K4 M as viscosity enhancing agent. All the formulations except F7, F8 and F9 showed instantaneous gelation when contacted with simulated tear fluid (STF), formulation F6 showed best gelation property amongst all other. The In vitro drug release data of the optimized formulation was subjected to goodness of fit test by linear regression analysis according to zero order, first order Higuchi and Korsmeyer peppas release kinetic equation in order to determine the mechanism of drug release. When the regression coefficient values of were compared, it was observed that ‘r’ values of first order was maximum hence indicating drug release from formulations was found to follow Korsmeyer peppas release kinetics. Evaluation of in situ gel is determined to ensure that the prepared preparation meets the standard and is safe. In the chemical evaluation in situ gel determined the diffusion of the active substance of a compound by measuring its concentration.
Hey words: Suprofen, Sodium Alginate, HPMC E 50 LV, HPMC K4 M

Cite This Article:

Please cite this article in press Umesh Kumar et al, Formulation Development And Evaluation Of Ocular In Situ Gel Of NSAIDS Drug For Effective Treatment Of Eye Disease., Indo Am. J. P. Sci, 2022; 09(6).,

Number of Downloads : 10


1. Nalla A and Chinnala KM. In -situ ophthalmic drug delivery systems –An Overview , Indo Am. J. Pharm. Sci. 2016; 3(3): 202-208.
2. PeppasNA, LangerR. New challenges in biomaterials. Science 1994; 263(5154):1715-1720.
3. Swapnil S. A review on polymers used in novel in situ gel formulation for ocular drug delivery and their evaluation. Journal of biological and scientific opinion 2003; 1(2):132-137.
4. Hajare A et al. A rational approach to ocular drug delivery systems: A overview. World journal of pharmaceutical research 2014; 3(2):3324-3348.
5. Bucolo C, Drago F and Salomone S.Ocular drug delivery: a clue from nanotechnology. Frontiers in Pharmacology 2012:3; 1-3.
6. Mali MN, Hajare AA. In-situgel forming systems for sustained ocular drug delivery system. European Industrial Pharmacy 2010; 5:17-20.
7. Jain GK, Pathan SA, Akhter S. Microscopic and spectroscopic evaluation of novel PLGA-chitosan nanoplates as an ocular delivery systems. Colloids and Surface B2011; 82: 397-403.
8. Deshmukh G et al. Evaluation of eye irritation potential of aqueous leaf extract of Achyranthes aspera by in vitro and in vivo method. Int Schol Res Network2012; 1-5.
9. Heppenheimer A et al. Comparative evaluation of cosmetic formulation with different alternative methods for eye irritation. Japanese Society for Alternatives to Animal Experiments2007; 505-507.
10. Urtti A, Pipkin J, Rork G, Repta A: Controlled drug delivery devices for experimental ocular studies with timolol in vitror elease studies, International Journal of Pharmaceutics 1990; 61: 235-240.